Efficacy of Preerythrocytic and Blood-Stage Malaria Vaccines Can Be Assessed in Small Sporozoite Challenge Trials in Human Volunteers
- 21 May 2012
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 206 (3) , 319-323
- https://doi.org/10.1093/infdis/jis355
Abstract
The development of a vaccine against malaria has public health priority. In a controlled setting, preliminary data on the efficacy of Plasmodium falciparum vaccine candidates can be obtained by exposing immunized human volunteers to the bites of laboratory-reared P. falciparum–infected mosquitoes. Using empirical data, we show that these trials, with small numbers of volunteers, are sufficiently powered to detect protective biological effects induced by preerythrocytic and/or blood-stage candidate vaccines if parasitemia is measured daily by quantitative polymerase chain reaction. Sporozoite challenge trials are thus a powerful tool for early selection of candidates that warrant efficacy of trials in the field.Keywords
This publication has 12 references indexed in Scilit:
- First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African ChildrenNew England Journal of Medicine, 2011
- Experimental human challenge infections can accelerate clinical malaria vaccine developmentNature Reviews Immunology, 2010
- Randomized double-blind controlled Phase I/IIa trial to assess the efficacy of malaria vaccine PfCS102 to protect against challenge with P. falciparumVaccine, 2010
- Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-γ/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infectionVaccine, 2010
- Heterogeneity in malaria exposure and vaccine response: implications for the interpretation of vaccine efficacy trialsMalaria Journal, 2010
- Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02APLOS ONE, 2009
- A DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccine Encoding Thrombospondin-Related Adhesion Protein but Not Circumsporozoite Protein Partially Protects Healthy Malaria-Naive Adults against Plasmodium falciparum Sporozoite ChallengeInfection and Immunity, 2006
- TESTING VACCINES IN HUMAN EXPERIMENTAL MALARIA: STATISTICAL ANALYSIS OF PARASITEMIA MEASURED BY A QUANTITATIVE REAL-TIME POLYMERASE CHAIN REACTIONThe American Journal of Tropical Medicine and Hygiene, 2004
- Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparumThe Lancet, 2002
- Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCRMolecular and Biochemical Parasitology, 2001